Veracyte, Inc.
VCYT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $2 | $2 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $2 | $2 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 23.5% | 21.8% | 35.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 66.9% | 68.7% | 65.7% | 66.1% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 11% | -13.7% | -2.4% | -27.4% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 5.4% | -20.6% | -12.3% | -34.4% |
| EPS Diluted | 0.31 | -1.02 | -0.51 | -1.11 |
| % Growth | 130.4% | -100% | 54.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |